SPHS - Sophiris Bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
-
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
5,374
10,710
6,186
3,538
9,862
Selling General and Administrative
4,793
4,429
5,732
6,768
3,626
Total Operating Expenses
10,167
15,139
11,918
10,306
13,488
Operating Income or Loss
-10,167
-15,139
-11,918
-10,306
-13,488
Interest Expense
644
684
207
292
690
Total Other Income/Expenses Net
10,636
8,712
3,259
-522
-41
Income Before Tax
37
-6,778
-8,628
-11,164
-14,197
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
37
-6,778
-8,628
-11,164
-14,197
Net Income
37
-6,778
-8,628
-11,164
-14,197
Net Income available to common shareholders
37
-6,778
-8,628
-11,164
-14,197
Reported EPS
Basic
-
-0.23
-0.29
-0.49
-0.84
Diluted
-
-0.23
-0.29
-0.49
-0.84
Weighted average shares outstanding
Basic
-
30,115
30,111
23,002
16,881
Diluted
-
30,115
30,111
23,002
16,881
EBITDA
-
-6,092
-8,417
-10,860
-13,487